ArticleTherapeutic advances in respiratory disease

Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies.

Thomas B Casale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.